The Institutional Biosafety Committee (IBC) reviews, approves, and oversees research that involves the use of recombinant or
synthetic DNA/RNA and other biohazardous agents. The IBC carries out these functions pursuant to
requirements set forth by the National Institutes of Health (NIH), Centers for Disease Control and Prevention, University policy, and federal,
state, and local regulations.
Biological Use Authorization (BUA) from the IBC and Environmental Health and Safety is required for work involving biohazards, including recombinant or synthetic DNA/RNA.
See the Biological Use Authorization webpage for the application, information regarding the approval
process, IBC meeting dates, and submission deadlines. See the IBC Charter for more information.
The IBC meeting is held on the third Wednesday of every month from 10:00 a.m. to 12:00 p.m. in
William H. Foege Bioengineering, Room N130A. The current meeting agenda
is posted at least 24 hours prior to the meeting.
Contact the Office of Public Records to request additional meeting minutes.
Contact the IBC Coordinator at email@example.com or 206.221.7770.